NewAmsterdam Pharma Company N.V.
NAMS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$241,598 | -$176,937 | -$22,634 | -$41,785 |
| Dep. & Amort. | $113 | $49 | $9 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $33,619 | $0 | $4,117 | $1,244 |
| Change in WC | -$32,674 | $5,866 | $10,373 | $4,470 |
| Other Non-Cash | $81,976 | $29,804 | $18,800 | $6,554 |
| Operating Cash Flow | -$158,564 | -$141,218 | $10,665 | -$29,512 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$672 | -$24 | -$221 | -$24 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$62,176 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$62,848 | -$24 | -$221 | -$24 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $747 | $0 |
| Stock Issued | $645,507 | $8,912 | $396,952 | $84,704 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14,000 | $0 | -$5,794 | $0 |
| Financing Cash Flow | $659,507 | $8,912 | $391,905 | $84,704 |
| Forex Effect | -$6,802 | $5,052 | $5,248 | -$4,683 |
| Net Chg. in Cash | $431,293 | -$127,278 | $407,597 | $50,485 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $340,450 | $467,728 | $60,131 | $9,646 |
| End Cash | $771,743 | $340,450 | $467,728 | $60,131 |
| Free Cash Flow | -$159,236 | -$141,242 | $10,444 | -$29,536 |